↓ Skip to main content

PR-104 a bioreductive pre-prodrug combined with gemcitabine or docetaxel in a phase Ib study of patients with advanced solid tumours

Overview of attention for article published in BMC Cancer, October 2012
Altmetric Badge

Citations

dimensions_citation
50 Dimensions

Readers on

mendeley
57 Mendeley